With effect from April 2017
Sun Pharmaceutical Industries announced that the Company have received a letter intimating to the Company from the Company's Chief Financial Officer (CFO), Uday Baldota that he would be tendering his resignation as the CFO of Sun Pharmaceutical Industries to be effective with effect from in and around April, 2017 due to his shifting to United States of America in and around April, 2017 to look after the business of Taro Pharmaceutical Industries, a subsidiary of Sun Pharmaceutical Industries as its Chief Executive Officer.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
